Focal, Inc.
This article was originally published in The Gray Sheet
Executive Summary
FDA's General and Plastic Surgery Devices Advisory Panel will review the firm's premarket approval application for FocalSeal-L surgical sealant at a May 8 meeting. Under agency expedited review since June 1999, the product is designed to reduce or eliminate air leaks following pulmonary surgery